Industry Research Reports

Home > Reports > Service & Software > Spatial Genomics & Transcriptomics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Spatial Genomics & Transcriptomics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Service & Software

Published Date: 2026-07-09

Pages: 103 Pages

Report ld: 6848294

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Spatial Genomics & Transcriptomics Market Size(US$)

CAGR 2026-2032

6.2%

Market Size,2032

USD 333

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 232 million

Market Forecast in 2032(Value)

US$ 333 million

CAGR

6.2%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Spatial Genomics & Transcriptomics was estimated to be worth US$ 220 million in 2025 and is projected to reach US$ 333 million, growing at a CAGR of 6.2% from 2026 to 2032.

The North American market for Spatial Genomics & Transcriptomics was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.

The Asia-Pacific market for Spatial Genomics & Transcriptomics was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.

The European market for Spatial Genomics & Transcriptomics was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.

The global key companies in the Spatial Genomics & Transcriptomics market include NanoString Technologies, Seven Bridges Genomic, Horizon Discovery Group, CARTANA, Advanced Cell Diagnostics, 10x Genomics, Dovetail Genomics, Illumina, S2 Genomics, etc. In 2025, the five largest players accounted for approximately % of revenue.

This report provides a comprehensive view of the global market for Spatial Genomics & Transcriptomics, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Spatial Genomics & Transcriptomics market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Spatial Genomics & Transcriptomics.

MARKET SEGMENTATION

By Company

NanoString Technologies
Seven Bridges Genomic
Horizon Discovery Group
CARTANA
Advanced Cell Diagnostics
10x Genomics
Dovetail Genomics
Illumina
S2 Genomics

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Instruments
Consumables
Software

Segment by Application

Academic Research
Pharmaceutical Manufacturer
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.

Chapter 2: Provides a detailed analysis of the Spatial Genomics & Transcriptomics companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Spatial Genomics & Transcriptomics revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Spatial Genomics & Transcriptomics revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.

Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Spatial Genomics & Transcriptomics Product Introduction

1.2 Global Spatial Genomics & Transcriptomics Market Size Forecast (2021–2032)

1.3 Spatial Genomics & Transcriptomics Market Trends & Drivers

1.3.1 Spatial Genomics & Transcriptomics Industry Trends

1.3.2 Spatial Genomics & Transcriptomics Market Drivers & Opportunities

1.3.3 Spatial Genomics & Transcriptomics Market Challenges

1.3.4 Spatial Genomics & Transcriptomics Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Spatial Genomics & Transcriptomics Players Revenue Ranking (2025)

2.2 Global Spatial Genomics & Transcriptomics Revenue by Company (2021–2026)

2.3 Key Companies’ R&D and Operations Footprint and Headquarters

2.4 Key Companies Spatial Genomics & Transcriptomics Product Offerings

2.5 Key Companies General Availability (GA) Timeline for Spatial Genomics & Transcriptomics

2.6 Spatial Genomics & Transcriptomics Market Competitive Analysis

2.6.1 Spatial Genomics & Transcriptomics Market Concentration Rate (2021–2026)

2.6.2 Top 5 and Top 10 Global Companies by Spatial Genomics & Transcriptomics Revenue in 2025

2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Spatial Genomics & Transcriptomics revenue, 2025

2.7 Mergers & Acquisitions and Expansion

3 Segmentation Spatial Genomics & Transcriptomics Market Classification

3.1 Introduction by Type

3.1.1 Instruments

3.1.2 Consumables

3.1.3 Software

3.1.4 Global Spatial Genomics & Transcriptomics Sales Value by Type

3.1.4.1 Global Spatial Genomics & Transcriptomics Sales Value by Type (2021 vs 2025 vs 2032)

3.1.4.2 Global Spatial Genomics & Transcriptomics Sales Value, by Type (2021–2032)

3.1.4.3 Global Spatial Genomics & Transcriptomics Sales Value, by Type (%), 2021–2032

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Academic Research

4.1.2 Pharmaceutical Manufacturer

4.1.3 Others

4.2 Global Spatial Genomics & Transcriptomics Sales Value by Application

4.2.1 Global Spatial Genomics & Transcriptomics Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Spatial Genomics & Transcriptomics Sales Value by Application (2021–2032)

4.2.3 Global Spatial Genomics & Transcriptomics Sales Value by Application (%), 2021–2032

5 Segmentation by Region

5.1 Global Spatial Genomics & Transcriptomics Sales Value by Region

5.1.1 Global Spatial Genomics & Transcriptomics Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Spatial Genomics & Transcriptomics Sales Value by Region (2021–2026)

5.1.3 Global Spatial Genomics & Transcriptomics Sales Value by Region (2027–2032)

5.1.4 Global Spatial Genomics & Transcriptomics Sales Value by Region (%), 2021–2032

5.2 North America

5.2.1 North America Spatial Genomics & Transcriptomics Sales Value, 2021–2032

5.2.2 North America Spatial Genomics & Transcriptomics Sales Value by Country (%), 2025 vs 2032

5.3 Europe

5.3.1 Europe Spatial Genomics & Transcriptomics Sales Value, 2021–2032

5.3.2 Europe Spatial Genomics & Transcriptomics Sales Value by Country (%), 2025 vs 2032

5.4 Asia Pacific

5.4.1 Asia Pacific Spatial Genomics & Transcriptomics Sales Value, 2021–2032

5.4.2 Asia Pacific Spatial Genomics & Transcriptomics Sales Value by Subregion (%), 2025 vs 2032

5.5 South America

5.5.1 South America Spatial Genomics & Transcriptomics Sales Value, 2021–2032

5.5.2 South America Spatial Genomics & Transcriptomics Sales Value by Country (%), 2025 vs 2032

5.6 Middle East & Africa

5.6.1 Middle East & Africa Spatial Genomics & Transcriptomics Sales Value, 2021–2032

5.6.2 Middle East & Africa Spatial Genomics & Transcriptomics Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Spatial Genomics & Transcriptomics Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Spatial Genomics & Transcriptomics Sales Value, 2021–2032

6.3 United States

6.3.1 United States Spatial Genomics & Transcriptomics Sales Value, 2021–2032

6.3.2 United States Spatial Genomics & Transcriptomics Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Spatial Genomics & Transcriptomics Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Spatial Genomics & Transcriptomics Sales Value, 2021–2032

6.4.2 Europe Spatial Genomics & Transcriptomics Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Spatial Genomics & Transcriptomics Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Spatial Genomics & Transcriptomics Sales Value, 2021–2032

6.5.2 China Spatial Genomics & Transcriptomics Sales Value by Type (%), 2025 vs 2032

6.5.3 China Spatial Genomics & Transcriptomics Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Spatial Genomics & Transcriptomics Sales Value, 2021–2032

6.6.2 Japan Spatial Genomics & Transcriptomics Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Spatial Genomics & Transcriptomics Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Spatial Genomics & Transcriptomics Sales Value, 2021–2032

6.7.2 South Korea Spatial Genomics & Transcriptomics Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Spatial Genomics & Transcriptomics Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Spatial Genomics & Transcriptomics Sales Value, 2021–2032

6.8.2 Southeast Asia Spatial Genomics & Transcriptomics Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Spatial Genomics & Transcriptomics Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Spatial Genomics & Transcriptomics Sales Value, 2021–2032

6.9.2 India Spatial Genomics & Transcriptomics Sales Value by Type (%), 2025 vs 2032

6.9.3 India Spatial Genomics & Transcriptomics Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 NanoString Technologies

7.1.1 NanoString Technologies Profile

7.1.2 NanoString Technologies Main Business

7.1.3 NanoString Technologies Spatial Genomics & Transcriptomics Products, Services, and Solutions

7.1.4 NanoString Technologies Spatial Genomics & Transcriptomics Revenue (US$ Million), 2021–2026

7.1.5 NanoString Technologies Recent Developments

7.2 Seven Bridges Genomic

7.2.1 Seven Bridges Genomic Profile

7.2.2 Seven Bridges Genomic Main Business

7.2.3 Seven Bridges Genomic Spatial Genomics & Transcriptomics Products, Services, and Solutions

7.2.4 Seven Bridges Genomic Spatial Genomics & Transcriptomics Revenue (US$ Million), 2021–2026

7.2.5 Seven Bridges Genomic Recent Developments

7.3 Horizon Discovery Group

7.3.1 Horizon Discovery Group Profile

7.3.2 Horizon Discovery Group Main Business

7.3.3 Horizon Discovery Group Spatial Genomics & Transcriptomics Products, Services, and Solutions

7.3.4 Horizon Discovery Group Spatial Genomics & Transcriptomics Revenue (US$ Million), 2021–2026

7.3.5 Horizon Discovery Group Recent Developments

7.4 CARTANA

7.4.1 CARTANA Profile

7.4.2 CARTANA Main Business

7.4.3 CARTANA Spatial Genomics & Transcriptomics Products, Services, and Solutions

7.4.4 CARTANA Spatial Genomics & Transcriptomics Revenue (US$ Million), 2021–2026

7.4.5 CARTANA Recent Developments

7.5 Advanced Cell Diagnostics

7.5.1 Advanced Cell Diagnostics Profile

7.5.2 Advanced Cell Diagnostics Main Business

7.5.3 Advanced Cell Diagnostics Spatial Genomics & Transcriptomics Products, Services, and Solutions

7.5.4 Advanced Cell Diagnostics Spatial Genomics & Transcriptomics Revenue (US$ Million), 2021–2026

7.5.5 Advanced Cell Diagnostics Recent Developments

7.6 10x Genomics

7.6.1 10x Genomics Profile

7.6.2 10x Genomics Main Business

7.6.3 10x Genomics Spatial Genomics & Transcriptomics Products, Services, and Solutions

7.6.4 10x Genomics Spatial Genomics & Transcriptomics Revenue (US$ Million), 2021–2026

7.6.5 10x Genomics Recent Developments

7.7 Dovetail Genomics

7.7.1 Dovetail Genomics Profile

7.7.2 Dovetail Genomics Main Business

7.7.3 Dovetail Genomics Spatial Genomics & Transcriptomics Products, Services, and Solutions

7.7.4 Dovetail Genomics Spatial Genomics & Transcriptomics Revenue (US$ Million), 2021–2026

7.7.5 Dovetail Genomics Recent Developments

7.8 Illumina

7.8.1 Illumina Profile

7.8.2 Illumina Main Business

7.8.3 Illumina Spatial Genomics & Transcriptomics Products, Services, and Solutions

7.8.4 Illumina Spatial Genomics & Transcriptomics Revenue (US$ Million), 2021–2026

7.8.5 Illumina Recent Developments

7.9 S2 Genomics

7.9.1 S2 Genomics Profile

7.9.2 S2 Genomics Main Business

7.9.3 S2 Genomics Spatial Genomics & Transcriptomics Products, Services, and Solutions

7.9.4 S2 Genomics Spatial Genomics & Transcriptomics Revenue (US$ Million), 2021–2026

7.9.5 S2 Genomics Recent Developments

8 Industry Chain Analysis

8.1 Spatial Genomics & Transcriptomics Value Chain

8.2 Spatial Genomics & Transcriptomics Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Cost Structure

8.3 Midstream Analysis

8.4 Downstream (Customer) Analysis

8.5 Sales Model and Sales Channelss

8.5.1 Spatial Genomics & Transcriptomics Sales Model

8.5.2 Sales Channels

8.5.3 Spatial Genomics & Transcriptomics Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Spatial Genomics & Transcriptomics Market Trends

Table 2. Spatial Genomics & Transcriptomics Market Drivers & Opportunities

Table 3. Spatial Genomics & Transcriptomics Market Challenges

Table 4. Spatial Genomics & Transcriptomics Market Restraints

Table 5. Global Spatial Genomics & Transcriptomics Revenue by Company (US$ Million), 2021–2026

Table 6. Global Spatial Genomics & Transcriptomics Revenue Market Share by Company (2021–2026)

Table 7. Key Companies’ R&D and Operations Footprint and Headquarters

Table 8. Key Companies Spatial Genomics & Transcriptomics Product Type

Table 9. Key Companies General Availability (GA) Timeline for Spatial Genomics & Transcriptomics

Table 10. Global Spatial Genomics & Transcriptomics Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Spatial Genomics & Transcriptomics revenue, 2025

Table 12. Mergers & Acquisitions and Expansion Plans

Table 13. Global Spatial Genomics & Transcriptomics Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 14. Global Spatial Genomics & Transcriptomics Sales Value by Type (US$ Million), 2021–2026

Table 15. Global Spatial Genomics & Transcriptomics Sales Value by Type (US$ Million), 2027–2032

Table 16. Global Spatial Genomics & Transcriptomics Sales Market Share in Value by Type (2021–2026)

Table 17. Global Spatial Genomics & Transcriptomics Sales Market Share in Value by Type (2027–2032)

Table 18. Global Spatial Genomics & Transcriptomics Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 19. Global Spatial Genomics & Transcriptomics Sales Value by Application (US$ Million), 2021–2026

Table 20. Global Spatial Genomics & Transcriptomics Sales Value by Application (US$ Million), 2027–2032

Table 21. Global Spatial Genomics & Transcriptomics Sales Market Share in Value by Application (2021–2026)

Table 22. Global Spatial Genomics & Transcriptomics Sales Market Share in Value by Application (2027–2032)

Table 23. Global Spatial Genomics & Transcriptomics Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 24. Global Spatial Genomics & Transcriptomics Sales Value by Region (US$ Million), 2021–2026

Table 25. Global Spatial Genomics & Transcriptomics Sales Value by Region (US$ Million), 2027–2032

Table 26. Global Spatial Genomics & Transcriptomics Sales Value by Region (%), 2021–2026

Table 27. Global Spatial Genomics & Transcriptomics Sales Value by Region (%), 2027–2032

Table 28. Key Countries/Regions Spatial Genomics & Transcriptomics Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 29. Key Countries/Regions Spatial Genomics & Transcriptomics Sales Value, (US$ Million), 2021–2026

Table 30. Key Countries/Regions Spatial Genomics & Transcriptomics Sales Value, (US$ Million), 2027–2032

Table 31. NanoString Technologies Basic Information List

Table 32. NanoString Technologies Description and Business Overview

Table 33. NanoString Technologies Spatial Genomics & Transcriptomics Products, Services, and Solutions

Table 34. Revenue (US$ Million) in Spatial Genomics & Transcriptomics Business of NanoString Technologies (2021–2026)

Table 35. NanoString Technologies Recent Developments

Table 36. Seven Bridges Genomic Basic Information List

Table 37. Seven Bridges Genomic Description and Business Overview

Table 38. Seven Bridges Genomic Spatial Genomics & Transcriptomics Products, Services, and Solutions

Table 39. Revenue (US$ Million) in Spatial Genomics & Transcriptomics Business of Seven Bridges Genomic (2021–2026)

Table 40. Seven Bridges Genomic Recent Developments

Table 41. Horizon Discovery Group Basic Information List

Table 42. Horizon Discovery Group Description and Business Overview

Table 43. Horizon Discovery Group Spatial Genomics & Transcriptomics Products, Services, and Solutions

Table 44. Revenue (US$ Million) in Spatial Genomics & Transcriptomics Business of Horizon Discovery Group (2021–2026)

Table 45. Horizon Discovery Group Recent Developments

Table 46. CARTANA Basic Information List

Table 47. CARTANA Description and Business Overview

Table 48. CARTANA Spatial Genomics & Transcriptomics Products, Services, and Solutions

Table 49. Revenue (US$ Million) in Spatial Genomics & Transcriptomics Business of CARTANA (2021–2026)

Table 50. CARTANA Recent Developments

Table 51. Advanced Cell Diagnostics Basic Information List

Table 52. Advanced Cell Diagnostics Description and Business Overview

Table 53. Advanced Cell Diagnostics Spatial Genomics & Transcriptomics Products, Services, and Solutions

Table 54. Revenue (US$ Million) in Spatial Genomics & Transcriptomics Business of Advanced Cell Diagnostics (2021–2026)

Table 55. Advanced Cell Diagnostics Recent Developments

Table 56. 10x Genomics Basic Information List

Table 57. 10x Genomics Description and Business Overview

Table 58. 10x Genomics Spatial Genomics & Transcriptomics Products, Services, and Solutions

Table 59. Revenue (US$ Million) in Spatial Genomics & Transcriptomics Business of 10x Genomics (2021–2026)

Table 60. 10x Genomics Recent Developments

Table 61. Dovetail Genomics Basic Information List

Table 62. Dovetail Genomics Description and Business Overview

Table 63. Dovetail Genomics Spatial Genomics & Transcriptomics Products, Services, and Solutions

Table 64. Revenue (US$ Million) in Spatial Genomics & Transcriptomics Business of Dovetail Genomics (2021–2026)

Table 65. Dovetail Genomics Recent Developments

Table 66. Illumina Basic Information List

Table 67. Illumina Description and Business Overview

Table 68. Illumina Spatial Genomics & Transcriptomics Products, Services, and Solutions

Table 69. Revenue (US$ Million) in Spatial Genomics & Transcriptomics Business of Illumina (2021–2026)

Table 70. Illumina Recent Developments

Table 71. S2 Genomics Basic Information List

Table 72. S2 Genomics Description and Business Overview

Table 73. S2 Genomics Spatial Genomics & Transcriptomics Products, Services, and Solutions

Table 74. Revenue (US$ Million) in Spatial Genomics & Transcriptomics Business of S2 Genomics (2021–2026)

Table 75. S2 Genomics Recent Developments

Table 76. Revenue (US$ Million) in Spatial Genomics & Transcriptomics Business of Company 40 (2021–2026)

Table 77. Company 40 Recent Developments

Table 78. Key Raw Materials Lists

Table 79. Key Suppliers of Raw Materials Lists

Table 80. Spatial Genomics & Transcriptomics Downstream Customers

Table 81. Spatial Genomics & Transcriptomics Distributors List

Table 82. Research Programs/Design for This Report

Table 83. Key Data Information from Secondary Sources

Table 84. Key Data Information from Primary Sources

List of Figures

Figure 1. Spatial Genomics & Transcriptomics Product Picture

Figure 2. Global Spatial Genomics & Transcriptomics Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Spatial Genomics & Transcriptomics Sales Value (US$ Million), 2021–2032

Figure 4. Spatial Genomics & Transcriptomics Report Years Considered

Figure 5. Global Spatial Genomics & Transcriptomics Players Revenue Ranking (US$ Million), 2025

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Spatial Genomics & Transcriptomics Revenue in 2025

Figure 7. Spatial Genomics & Transcriptomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 8. Instruments Picture

Figure 9. Consumables Picture

Figure 10. Software Picture

Figure 11. Global Spatial Genomics & Transcriptomics Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 12. Global Spatial Genomics & Transcriptomics Sales Value Market Share by Type, 2025 & 2032

Figure 13. Product Picture of Academic Research

Figure 14. Product Picture of Pharmaceutical Manufacturer

Figure 15. Product Picture of Others

Figure 16. Global Spatial Genomics & Transcriptomics Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 17. Global Spatial Genomics & Transcriptomics Sales Value Market Share by Application, 2025 & 2032

Figure 18. North America Spatial Genomics & Transcriptomics Sales Value (US$ Million), 2021–2032

Figure 19. North America Spatial Genomics & Transcriptomics Sales Value by Country (%), 2025 vs 2032

Figure 20. Europe Spatial Genomics & Transcriptomics Sales Value (US$ Million), 2021–2032

Figure 21. Europe Spatial Genomics & Transcriptomics Sales Value by Country (%), 2025 vs 2032

Figure 22. Asia Pacific Spatial Genomics & Transcriptomics Sales Value (US$ Million), 2021–2032

Figure 23. Asia Pacific Spatial Genomics & Transcriptomics Sales Value by Subregion (%), 2025 vs 2032

Figure 24. South America Spatial Genomics & Transcriptomics Sales Value (US$ Million), 2021–2032

Figure 25. South America Spatial Genomics & Transcriptomics Sales Value by Country (%), 2025 vs 2032

Figure 26. Middle East & Africa Spatial Genomics & Transcriptomics Sales Value (US$ Million), 2021–2032

Figure 27. Middle East & Africa Spatial Genomics & Transcriptomics Sales Value by Country (%), 2025 vs 2032

Figure 28. Key Countries/Regions Spatial Genomics & Transcriptomics Sales Value (%), 2021–2032

Figure 29. United States Spatial Genomics & Transcriptomics Sales Value (US$ Million), 2021–2032

Figure 30. United States Spatial Genomics & Transcriptomics Sales Value by Type (%), 2025 vs 2032

Figure 31. United States Spatial Genomics & Transcriptomics Sales Value by Application (%), 2025 vs 2032

Figure 32. Europe Spatial Genomics & Transcriptomics Sales Value (US$ Million), 2021–2032

Figure 33. Europe Spatial Genomics & Transcriptomics Sales Value by Type (%), 2025 vs 2032

Figure 34. Europe Spatial Genomics & Transcriptomics Sales Value by Application (%), 2025 vs 2032

Figure 35. China Spatial Genomics & Transcriptomics Sales Value (US$ Million), 2021–2032

Figure 36. China Spatial Genomics & Transcriptomics Sales Value by Type (%), 2025 vs 2032

Figure 37. China Spatial Genomics & Transcriptomics Sales Value by Application (%), 2025 vs 2032

Figure 38. Japan Spatial Genomics & Transcriptomics Sales Value (US$ Million), 2021–2032

Figure 39. Japan Spatial Genomics & Transcriptomics Sales Value by Type (%), 2025 vs 2032

Figure 40. Japan Spatial Genomics & Transcriptomics Sales Value by Application (%), 2025 vs 2032

Figure 41. South Korea Spatial Genomics & Transcriptomics Sales Value (US$ Million), 2021–2032

Figure 42. South Korea Spatial Genomics & Transcriptomics Sales Value by Type (%), 2025 vs 2032

Figure 43. South Korea Spatial Genomics & Transcriptomics Sales Value by Application (%), 2025 vs 2032

Figure 44. Southeast Asia Spatial Genomics & Transcriptomics Sales Value (US$ Million), 2021–2032

Figure 45. Southeast Asia Spatial Genomics & Transcriptomics Sales Value by Type (%), 2025 vs 2032

Figure 46. Southeast Asia Spatial Genomics & Transcriptomics Sales Value by Application (%), 2025 vs 2032

Figure 47. India Spatial Genomics & Transcriptomics Sales Value (US$ Million), 2021–2032

Figure 48. India Spatial Genomics & Transcriptomics Sales Value by Type (%), 2025 vs 2032

Figure 49. India Spatial Genomics & Transcriptomics Sales Value by Application (%), 2025 vs 2032

Figure 50. Spatial Genomics & Transcriptomics Value Chain

Figure 51. Spatial Genomics & Transcriptomics Cost Structure

Figure 52. Channels of Distribution (Direct Sales, and Distribution)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

Figure 55. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which region is expected to have the highest market share? zhanKai

For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 6.2% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.

What was the global market size of Spatial Genomics & Transcriptomics in 2026? shouQi

Which companies rank high in the global Spatial Genomics & Transcriptomics market? shouQi

What is the annual compound growth rate of the global Spatial Genomics & Transcriptomics market size from 2026 to 2032? shouQi

What was the global market size of Spatial Genomics & Transcriptomics in 2032? shouQi

Related Reports

Global Spatial Genomics & Transcriptomics Market Research Report 2026
The global Spatial Genomics & Transcriptomics market was valued at US$ 220 million in 2025 and is anticipated to reach US$ 333 million by 2032, at a CAGR of 6.2% from 2026 to 2032.
Published Date: 2026-04-21
Pages: 105
USD 2900.00
(Single User License)
Global Spatial Genomics & Transcriptomics Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Spatial Genomics & Transcriptomics market is projected to grow from US$ 208 million in 2024 to US$ 315 million by 2031, at a CAGR of 6.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-25
Pages: 127
USD 4900.00
(Single User License)
Global Spatial Genomics & Transcriptomics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Spatial Genomics & Transcriptomics market size was US$ 208 million in 2024 and is forecast to a readjusted size of US$ 315 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 76
USD 4250.00
(Single User License)
Spatial Genomics & Transcriptomics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Spatial Genomics & Transcriptomics was estimated to be worth US$ 208 million in 2024 and is forecast to a readjusted size of US$ 315 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 90
USD 3950.00
(Single User License)
Global Spatial Genomics & Transcriptomics Market Research Report 2025
The global market for Spatial Genomics & Transcriptomics was valued at US$ 208 million in the year 2024 and is projected to reach a revised size of US$ 315 million by 2031, growing at a CAGR of 6.2% during the forecast period.
Published Date: 2025-02-21
Pages: 74
USD 2900.00
(Single User License)
Global Spatial Genomics & Transcriptomics Market Insights, Forecast to 2030
Market Analysis and Insights: Global Spatial Genomics & Transcriptomics Market
Published Date: 2024-04-06
Pages: 91
USD 4900.00
(Single User License)
Global Spatial Genomics & Transcriptomics Market Research Report 2024
The global Spatial Genomics & Transcriptomics market was valued at US$ 184.2 million in 2023 and is anticipated to reach US$ 282.9 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030.
Published Date: 2024-01-10
Pages: 73
USD 2900.00
(Single User License)

Global Spatial Genomics & Transcriptomics Market Research Report 2026
The global Spatial Genomics & Transcriptomics market was valued at US$ 220 million in 2025 and is anticipated to reach US$ 333 million by 2032, at a CAGR of 6.2% from 2026 to 2032.
Published: 2026-04-21
Pages: 105
USD 2900.00 (Single User License)
Global Spatial Genomics & Transcriptomics Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Spatial Genomics & Transcriptomics market is projected to grow from US$ 208 million in 2024 to US$ 315 million by 2031, at a CAGR of 6.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-25
Pages: 127
USD 4900.00 (Single User License)
Global Spatial Genomics & Transcriptomics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Spatial Genomics & Transcriptomics market size was US$ 208 million in 2024 and is forecast to a readjusted size of US$ 315 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 76
USD 4250.00 (Single User License)
Spatial Genomics & Transcriptomics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Spatial Genomics & Transcriptomics was estimated to be worth US$ 208 million in 2024 and is forecast to a readjusted size of US$ 315 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 90
USD 3950.00 (Single User License)
Global Spatial Genomics & Transcriptomics Market Research Report 2025
The global market for Spatial Genomics & Transcriptomics was valued at US$ 208 million in the year 2024 and is projected to reach a revised size of US$ 315 million by 2031, growing at a CAGR of 6.2% during the forecast period.
Published: 2025-02-21
Pages: 74
USD 2900.00 (Single User License)
Global Spatial Genomics & Transcriptomics Market Insights, Forecast to 2030
Market Analysis and Insights: Global Spatial Genomics & Transcriptomics Market
Published: 2024-04-06
Pages: 91
USD 4900.00 (Single User License)
Global Spatial Genomics & Transcriptomics Market Research Report 2024
The global Spatial Genomics & Transcriptomics market was valued at US$ 184.2 million in 2023 and is anticipated to reach US$ 282.9 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030.
Published: 2024-01-10
Pages: 73
USD 2900.00 (Single User License)